Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Hot Flashes, PMS Structure/Function Claims Allowed Under Final Rule

This article was originally published in The Tan Sheet

Executive Summary

FDA will permit dietary supplement makers to make structure/function claims for "common, mild symptoms associated with normal life stages or processes." Examples of allowable claims include hot flashes associated with menopause and mild mood changes, cramps and edema related to the menstrual cycle.

You may also be interested in...



Tums Calcium For Life PMS, Bone Health Supplements Targeting Women

GlaxoSmithKline has expanded its Tums line to include two Calcium for Life supplements targeted at women: a PMS formula for the "physical and emotional" symptoms that accompany the condition and a Bone Health product.

Tums Calcium For Life PMS, Bone Health Supplements Targeting Women

GlaxoSmithKline has expanded its Tums line to include two Calcium for Life supplements targeted at women: a PMS formula for the "physical and emotional" symptoms that accompany the condition and a Bone Health product.

Tums Calcium For Life PMS, Bone Health Supplements Targeting Women

GlaxoSmithKline has expanded its Tums line to include two Calcium for Life supplements targeted at women: a PMS formula for the "physical and emotional" symptoms that accompany the condition and a Bone Health product.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS090745

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel